Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group In preclinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback